Exploring the antineoplastic potential of α-mangostin in breast cancer

doi:10.1007/s13659-025-00528-5

Abstract

Abstract: Among women, breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related mortality globally. Despite improvements in early detection and diagnosis, some risk factors have been on the rise, including the decline in birth rate, the use of oral contraceptives, and the escalation in alcohol consumption and obesity. Thus, there is an imperative urgent need to expand accessible prevention and treatment options for breast cancer. Regarding these tumors, several natural compounds have shown efficacy in slowing or preventing their progression, offering a promising therapeutic alternative. Among these, α-mangostin, a xanthone derived from mangosteen, has demonstrated promising antitumor effects against different malignancies, particularly breast cancer. The mechanisms involved in α-mangostin′s therapeutic effects include downregulation of oncogenic ion channels, modulation of cell cycle progression, suppression of oncogene expression, and interference with steroid and growth factor receptors signaling. This review thoroughly explores these mechanisms, as well as updates information on α-mangostin chemical structure and its potential as a coadjuvant to conventional breast cancer therapies. Furthermore, we provide scientifically supported insights for the development of clinically applicable α-mangostin-based treatments, highlighting the robust body of evidence supporting its cancer-fighting properties, despite the absence of clinical studies to date.

Key words: α-Mangostin, Breast cancer, Antineoplastic effects, Garcinia mangostana, Xanthone

摘要： Among women, breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related mortality globally. Despite improvements in early detection and diagnosis, some risk factors have been on the rise, including the decline in birth rate, the use of oral contraceptives, and the escalation in alcohol consumption and obesity. Thus, there is an imperative urgent need to expand accessible prevention and treatment options for breast cancer. Regarding these tumors, several natural compounds have shown efficacy in slowing or preventing their progression, offering a promising therapeutic alternative. Among these, α-mangostin, a xanthone derived from mangosteen, has demonstrated promising antitumor effects against different malignancies, particularly breast cancer. The mechanisms involved in α-mangostin′s therapeutic effects include downregulation of oncogenic ion channels, modulation of cell cycle progression, suppression of oncogene expression, and interference with steroid and growth factor receptors signaling. This review thoroughly explores these mechanisms, as well as updates information on α-mangostin chemical structure and its potential as a coadjuvant to conventional breast cancer therapies. Furthermore, we provide scientifically supported insights for the development of clinically applicable α-mangostin-based treatments, highlighting the robust body of evidence supporting its cancer-fighting properties, despite the absence of clinical studies to date.

关键词: α-Mangostin, Breast cancer, Antineoplastic effects, Garcinia mangostana, Xanthone

Daniela Amador-Martínez, Mizraim Flores, Rafael Vargas-Castro, Rocío García-Becerra, Euclides Avila, Lorenza Díaz, Janice García-Quiroz. Exploring the antineoplastic potential of α-mangostin in breast cancer[J]. Natural Products and Bioprospecting, 2025, 15(5): 43-43.

References

[1] Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. https://doi.org/10.3322/caac.21834.
[2] Bissoli I, Muscari C. Doxorubicin and α-mangostin oppositely affect luminal breast cancer cell stemness evaluated by a new retinaldehyde-dependent ALDH assay in MCF-7 tumor spheroids. Biomed Pharmacother. 2020;124:109927. https://doi.org/10.1016/j.biopha.2020.109927.
[3] Lara-Sotelo G, Díaz L, García-Becerra R, Avila E, Prado-García H, Morales-Guadarrama G, et al. α-mangostin synergizes the antineoplastic effects of 5-fluorouracil allowing a significant dose reduction in breast cancer cells. Processes. 2021;9(3):458. https://doi.org/10.3390/pr9030458.
[4] Vargas-Castro R, Garcia-Becerra R, Diaz L, Avila E, Ordaz-Rosado D, Bernadez-Vallejo SV, et al. Enhancing tamoxifen therapy with α-mangostin: synergistic antiproliferative effects on breast cancer cells and potential reduced endometrial impact. Pharmaceuticals. 2023. https://doi.org/10.3390/ph16111576.
[5] Alam M, Rashid S, Fatima K, Adnan M, Shafie A, Akhtar MS, et al. Biochemical features and therapeutic potential of α-mangostin: mechanism of action, medicinal values, and health benefits. Biomed Pharmacother. 2023;163:114710. https://doi.org/10.1016/j.biopha.2023.114710.
[6] Klein-Junior LC, Campos A, Niero R, Correa R, Vander Heyden Y, Filho VC. Xanthones and cancer: from natural sources to mechanisms of action. Chem Biodivers. 2020;17(2): e1900499. https://doi.org/10.1002/cbdv.201900499.
[7] Majdalawieh AF, Terro TM, Ahari SH, Abu-Yousef IA. Alpha-mangostin: a xanthone derivative in mangosteen with potent anti-cancer properties. Biomolecules. 2024. https://doi.org/10.3390/biom14111382.
[8] Nauman MC, Johnson JJ. The purple mangosteen (Garcinia mangostana): defining the anticancer potential of selected xanthones. Pharmacol Res. 2022;175:106032. https://doi.org/10.1016/j.phrs.2021.106032.
[9] Bi C, Xu H, Yu J, Ding Z, Liu Z. Botanical characteristics, chemical components, biological activity, and potential applications of mangosteen. PeerJ. 2023;11: e15329. https://doi.org/10.7717/peerj.15329.
[10] Díaz-Fuentes VH, Donjuan-Leobardo I, Díaz-Hernández BG. Phenological grown stages of mangostan (Garcinia mangostana L.) in the Soconusco Region, Chiapas Mexico, according to the BBCH extended scale. Horticult Int J. 2023;7(4):178-86. https://doi.org/10.15406/hij.2023.07.00293.
[11] Osman MB, Milan AR. Mangosteen-Garcinia mangostana L. Southampton: Southampton Centre for Underutilised Crops, University of Southampton; 2006.
[12] Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol. 2008;46(10):3227-39. https://doi.org/10.1016/j.fct.2008.07.024.
[13] Ansori ANM, Fadholly A, Hayaza S, Susilo RJK, Inayatillah B, Winarni D, et al. A review on medicinal properties of mangosteen (Garcinia mangostana L.). Res J Pharm and Tech. 2019;13(2):9.
[14] Sen AK, Sarkar KK, Mazumder PC, Banerji N, Uusvouri R, Haset TA. A xanthone from Garcinia mangostana. Phytochem. 1980;19(10):2223-5.
[15] Akao Y, Nakagawa Y, Nozawa Y. Anti-cancer effects of xanthones from pericarps of mangosteen. Int J Mol Sci. 2008;9(3):355-70. https://doi.org/10.3390/ijms9030355.
[16] Gunter NV, Teh SS, Lim YM, Mah SH. Natural xanthones and skin inflammatory diseases: multitargeting mechanisms of action and potential application. Front Pharmacol. 2020;11: 594202. https://doi.org/10.3389/fphar.2020.594202.
[17] Badiali C, Petruccelli V, Brasili E, Pasqua G. Xanthones: biosynthesis and trafficking in plants, fungi and lichens. Plants. 2023. https://doi.org/10.3390/plants12040694.
[18] Pinto MMM, Palmeira A, Fernandes C, Resende D, Sousa E, Cidade H, et al. From natural products to new synthetic small molecules: a journey through the world of xanthones. Molecules. 2021. https://doi.org/10.3390/molecules26020431.
[19] See I, Ee GCL, Jong VYM, Teh SS, Acuna CLC, Mah SH. Cytotoxic activity of phytochemicals from Garcinia mangostana L. and G. benthamiana (Planch. & Triana) Pipoly against breast cancer cells. Nat Prod Res. 2021;35(24):6184-9. https://doi.org/10.1080/14786419.2020.1836629.
[20] Suksamrarn S, Komutiban O, Ratananukul P, Chimnoi N, Lartpornmatulee N, Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharm Bull. 2006;54(3):301-5. https://doi.org/10.1248/cpb.54.301.
[21] Chi XQ, Zi CT, Li HM, Yang L, Lv YF, Li JY, et al. Design, synthesis and structure-activity relationships of mangostin analogs as cytotoxic agents. RSC Adv. 2018;8(72):41377-88. https://doi.org/10.1039/c8ra08409b.
[22] Vemu B, Nauman MC, Veenstra JP, Johnson JJ. Structure activity relationship of xanthones for inhibition of cyclin dependent kinase 4 from mangosteen (Garcinia mangostana L.). Int J Nutr. 2019;4(2):38-45.
[23] Jung HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem. 2006;54(6):2077-82. https://doi.org/10.1021/jf052649z.
[24] Mahabusarakam W, Wiriyachitra P, Taylor WC. Chemical constituents of Garcinia mangostana. J Nat Prod. 1987;50(3):474-8.
[25] Zarena AS, Udaya Sankar K. Supercritical carbon dioxide extraction of xanthones with antioxidant activity from Garcinia mangostana: characterization by HPLC/LC-ESI-MS. J Supercrit Fluids. 2009;49:330-7. https://doi.org/10.1016/j.supflu.2009.03.004.
[26] Wittenauer J, Falk S, Schweiggert-Weiz U, Carle R. Characterisation and quantification of xanthones from the aril and pericarp of mangosteens (Garcinia mangostana L.) and a mangosteen containing functional beverage by HPLC-DAD-MSn. Food Chem. 2012;134:445-52. https://doi.org/10.1016/j.foodchem.2012.02.094.
[27] Walker EB. HPLC analysis of selected xanthones in mangosteen fruit. J Sep Sci. 2007;30(9):1229-34. https://doi.org/10.1002/jssc.200700024.
[28] Bumrungpert A, Kalpravidh RW, Suksamrarn S, Chaivisuthangkura A, Chitchumroonchokchai C, Failla ML. Bioaccessibility, biotransformation, and transport of alpha-mangostin from Garcinia mangostana (Mangosteen) using simulated digestion and Caco-2 human intestinal cells. Mol Nutr Food Res. 2009;53(Suppl 1):S54-61. https://doi.org/10.1002/mnfr.200800260.
[29] Suksamrarn S, Suwannapoch N, Phakhodee W, Thanuhiranlert J, Ratananukul P, Chimnoi N, et al. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem Pharm Bull. 2003;51(7):857-9. https://doi.org/10.1248/cpb.51.857.
[30] Verma N, Pandit S, Kumar A, Yadav G, Giri SK, Lahiri D, et al. Recent update on active biological molecules in generating the anticancerous therapeutic potential of Garcinia mangostana. Appl Biochem Biotechnol. 2022;194(10):4724-44. https://doi.org/10.1007/s12010-022-04031-2.
[31] Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol. 2008;46(2):688-93. https://doi.org/10.1016/j.fct.2007.09.096.
[32] Gutierrez-Orozco F, Chitchumroonchokchai C, Lesinski GB, Suksamrarn S, Failla ML. Alpha-mangostin: anti-inflammatory activity and metabolism by human cells. J Agric Food Chem. 2013;61(16):3891-900. https://doi.org/10.1021/jf4004434.
[33] Chairungsrilerd N, Furukawa K, Ohta T, Nozoe S, Ohizumi Y. Pharmacological properties of alpha-mangostin, a novel histamine H1 receptor antagonist. Eur J Pharmacol. 1996;314(3):351-6. https://doi.org/10.1016/s0014-2999(96)00562-6.
[34] Sivaranjani M, Prakash M, Gowrishankar S, Rathna J, Pandian SK, Ravi AV. In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms. Appl Microbiol Biotechnol. 2017;101(8):3349-59. https://doi.org/10.1007/s00253-017-8231-7.
[35] Kaomongkolgit R, Jamdee K, Chaisomboon N. Antifungal activity of alpha-mangostin against Candida albicans. J Oral Sci. 2009;51(3):401-6. https://doi.org/10.2334/josnusd.51.401.
[36] Chen SX, Wan M, Loh BN. Active constituents against HIV-1 protease from Garcinia mangostana. Planta Med. 1996;62(4):381-2. https://doi.org/10.1055/s-2006-957916.
[37] Shaneyfelt ME, Burke AD, Graff JW, Jutila MA, Hardy ME. Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay. Virol J. 2006;3:68. https://doi.org/10.1186/1743-422X-3-68.
[38] Tarasuk M, Songprakhon P, Chimma P, Sratongno P, Na-Bangchang K, Yenchitsomanus PT. Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression. Virus Res. 2017;240:180-9. https://doi.org/10.1016/j.virusres.2017.08.011.
[39] Sugiyanto Z, Yohan B, Hadisaputro S, Dharmana E, Suharti C, Winarto, et al. Inhibitory effect of alpha-mangostin to dengue virus replication and cytokines expression in human peripheral blood mononuclear cells. Nat Prod Bioprospect. 2019;9(5):345-9. https://doi.org/10.1007/s13659-019-00218-z.
[40] Panda K, Alagarasu K, Patil P, Agrawal M, More A, Kumar NV, et al. In vitro antiviral activity of alpha-mangostin against dengue virus serotype-2 (DENV-2). Molecules. 2021. https://doi.org/10.3390/molecules26103016.
[41] Patil P, Agrawal M, Almelkar S, Jeengar MK, More A, Alagarasu K, et al. In vitro and in vivo studies reveal alpha-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus. Virol J. 2021;18(1):47. https://doi.org/10.1186/s12985-021-01517-z.
[42] Hidayat S, Ibrahim FM, Pratama KF, Muchtaridi M. The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods. J Adv Pharm Technol Res. 2021;12(3):285-90. https://doi.org/10.4103/japtr.JAPTR_299_20.
[43] Diaz L, Bernadez-Vallejo SV, Vargas-Castro R, Avila E, Gomez-Ceja KA, Garcia-Becerra R, et al. The phytochemical α-mangostin inhibits cervical cancer cell proliferation and tumor growth by downregulating E6/E7-HPV oncogenes and KCNH1 gene expression. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24033055.
[44] Yongpitakwattana P, Morchang A, Panya A, Sawasdee N, Yenchitsomanus PT. Alpha-mangostin inhibits dengue virus production and pro-inflammatory cytokine/chemokine expression in dendritic cells. Arch Virol. 2021;166(6):1623-32. https://doi.org/10.1007/s00705-021-05017-x.
[45] Upegui Y, Robledo SM, Gil Romero JF, Quinones W, Archbold R, Torres F, et al. In vivo antimalarial activity of alpha-mangostin and the new xanthone delta-mangostin. Phytother Res. 2015;29(8):1195-201. https://doi.org/10.1002/ptr.5362.
[46] Mekseepralard C, Areebambud C, Suksamrarn S, Jariyapongskul A. Effects of long-term alpha-mangostin supplementation on hyperglycemia and insulin resistance in type 2 diabetic rats induced by high fat diet and low dose streptozotocin. J Med Assoc Thai. 2015;98(Suppl 10):S23-30.
[47] Eisvand F, Imenshahidi M, Ghasemzadeh Rahbardar M, Tabatabaei Yazdi SA, Rameshrad M, Razavi BM, et al. Cardioprotective effects of alpha-mangostin on doxorubicin-induced cardiotoxicity in rats. Phytother Res. 2022;36(1):506-24. https://doi.org/10.1002/ptr.7356.
[48] Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007;21(6):336-9. https://doi.org/10.1002/jbt.20199.
[49] Fu T, Li H, Zhao Y, Cai E, Zhu H, Li P, et al. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice. Biomed Pharmacother. 2018;106:896-901. https://doi.org/10.1016/j.biopha.2018.07.034.
[50] Tiwari A, Khera R, Rahi S, Mehan S, Makeen HA, Khormi YH, et al. Neuroprotective effect of α-mangostin in ameliorating propionic acid-induced experimental model of autism in wistar rats. Brain Sci. 2021. https://doi.org/10.3390/brainsci11030288.
[51] Kasemwattanaroj P, Moongkarndi P, Pattanapanyasat K, Mangmool S, Rodpai E, Samer J, et al. Immunomodulatory activities of alpha-mangostin on peripheral blood mononuclear cells. Nat Prod Commun. 2013;8(9):1257-60.
[52] Aukkanimart R, Boonmars T, Sriraj P, Sripan P, Songsri J, Ratanasuwan P, et al. In vitro and in vivo inhibitory effects of alpha-mangostin on cholangiocarcinoma cells and allografts. Asian Pac J Cancer Prev. 2017;18(3):707-13. https://doi.org/10.22034/APJCP.2017.18.3.707.
[53] Sato A, Fujiwara H, Oku H, Ishiguro K, Ohizumi Y. Alpha-mangostin induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cells. J Pharmacol Sci. 2004;95(1):33-40. https://doi.org/10.1254/jphs.95.33.
[54] Chao AC, Hsu YL, Liu CK, Kuo PL. Alpha-mangostin, a dietary xanthone, induces autophagic cell death by activating the AMP-activated protein kinase pathway in glioblastoma cells. J Agric Food Chem. 2011;59(5):2086-96. https://doi.org/10.1021/jf1042757.
[55] Krajarng A, Nilwarankoon S, Suksamrarn S, Watanapokasin R. Antiproliferative effect of alpha-mangostin on canine osteosarcoma cells. Res Vet Sci. 2012;93(2):788-94. https://doi.org/10.1016/j.rvsc.2012.01.015.
[56] Kaomongkolgit R, Chaisomboon N, Pavasant P. Apoptotic effect of alpha-mangostin on head and neck squamous carcinoma cells. Arch Oral Biol. 2011;56(5):483-90. https://doi.org/10.1016/j.archoralbio.2010.10.023.
[57] Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, et al. Alpha-mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis. 2012;33(2):413-9. https://doi.org/10.1093/carcin/bgr291.
[58] Hung SH, Shen KH, Wu CH, Liu CL, Shih YW. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. J Agric Food Chem. 2009;57(4):1291-8. https://doi.org/10.1021/jf8032683.
[59] Shan T, Cui XJ, Li W, Lin WR, Lu HW, Li YM, et al. Alpha-mangostin suppresses human gastric adenocarcinoma cells in vitro via blockade of Stat3 signaling pathway. Acta Pharmacol Sin. 2014;35(8):1065-73. https://doi.org/10.1038/aps.2014.43.
[60] Ma Y, Yu W, Shrivastava A, Srivastava RK, Shankar S. Inhibition of pancreatic cancer stem cell characteristics by α‐mangostin: molecular mechanisms involving Sonic hedgehog and Nanog. J Cell Mol Med. 2019;23(4):2719-30. https://doi.org/10.1111/jcmm.14178.
[61] Verma RK, Yu W, Shrivastava A, Shankar S, Srivastava RK. Alpha-mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice. Sci Rep. 2016;6:32743. https://doi.org/10.1038/srep32743.
[62] Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, et al. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Lett. 2014;347(1):129-38. https://doi.org/10.1016/j.canlet.2014.02.003.
[63] Phan TKT, Shahbazzadeh F, Pham TTH, Kihara T. Alpha-mangostin inhibits the migration and invasion of A549 lung cancer cells. PeerJ. 2018;6: e5027. https://doi.org/10.7717/peerj.5027.
[64] Lee CH, Ying TH, Chiou HL, Hsieh SC, Wen SH, Chou RH, et al. Alpha-mangostin induces apoptosis through activation of reactive oxygen species and ASK1/p38 signaling pathway in cervical cancer cells. Oncotarget. 2017;8(29):47425-39. https://doi.org/10.18632/oncotarget.17659.
[65] Jo MK, Moon CM, Kim EJ, Kwon JH, Fei X, Kim SE, et al. Suppressive effect of alpha-mangostin for cancer stem cells in colorectal cancer via the Notch pathway. BMC Cancer. 2022;22(1):341. https://doi.org/10.1186/s12885-022-09414-6.
[66] Ittiudomrak T, Puthong S, Roytrakul S, Chanchao C. Alpha-mangostin and apigenin induced cell cycle arrest and programmed cell death in SKOV-3 ovarian cancer cells. Toxicol Res. 2019;35(2):167-79. https://doi.org/10.5487/TR.2019.35.2.167.
[67] Yu Y, Fei Z, Qin L. Anticancer effects of alpha-mangostin in OVACAR-3 human ovarian carcinoma cells are mediated via involvement of reactive oxygen species, mitochondrial -mediated apoptosis, suppression of cell migration and invasion and m-TOR/PI3K/AKT signaling pathway. J BUON. 2020;25(5):2293-300.
[68] Wang JJ, Sanderson BJ, Zhang W. Cytotoxic effect of xanthones from pericarp of the tropical fruit mangosteen (Garcinia mangostana Linn.) on human melanoma cells. Food Chem Toxicol. 2011;49(9):2385-91. https://doi.org/10.1016/j.fct.2011.06.051.
[69] Chen CM, Hsieh SC, Lin CL, Lin YS, Tsai JP, Hsieh YH. Alpha-mangostin suppresses the metastasis of human renal carcinoma cells by targeting MEK/ERK expression and MMP-9 transcription activity. Cell Physiol Biochem. 2017;44(4):1460-70. https://doi.org/10.1159/000485582.
[70] Zhu X, Li J, Ning H, Yuan Z, Zhong Y, Wu S, et al. Alpha-mangostin induces apoptosis and inhibits metastasis of breast cancer cells via regulating RXRalpha-AKT signaling pathway. Front Pharmacol. 2021;12:739658. https://doi.org/10.3389/fphar.2021.739658.
[71] Mardianingrum R, Yusuf M, Hariono M, Mohd Gazzali A, Muchtaridi M. Alpha-mangostin and its derivatives against estrogen receptor alpha. J Biomol Struct Dyn. 2022;40(6):2621-34. https://doi.org/10.1080/07391102.2020.1841031.
[72] Huang W, Liang Y, Ma X. Alpha-mangostin induces endoplasmic reticulum stress and autophagy which count against fatty acid synthase inhibition mediated apoptosis in human breast cancer cells. Cancer Cell Int. 2019;19:151. https://doi.org/10.1186/s12935-019-0869-z.
[73] Scolamiero G, Pazzini C, Bonafe F, Guarnieri C, Muscari C. Effects of alpha-mangostin on viability, growth and cohesion of multicellular spheroids derived from human breast cancer cell lines. Int J Med Sci. 2018;15(1):23-30. https://doi.org/10.7150/ijms.22002.
[74] Kritsanawong S, Innajak S, Imoto M, Watanapokasin R. Antiproliferative and apoptosis induction of alpha-mangostin in T47D breast cancer cells. Int J Oncol. 2016;48(5):2155-65. https://doi.org/10.3892/ijo.2016.3399.
[75] Li P, Tian W, Ma X. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol Cancer. 2014;13:138. https://doi.org/10.1186/1476-4598-13-138.
[76] Won YS, Lee JH, Kwon SJ, Kim JY, Park KH, Lee MK, et al. Alpha-mangostin-induced apoptosis is mediated by estrogen receptor alpha in human breast cancer cells. Food Chem Toxicol. 2014;66:158-65. https://doi.org/10.1016/j.fct.2014.01.040.
[77] Kurose H, Shibata MA, Iinuma M, Otsuki Y. Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with alpha-mangostin extracted from mangosteen pericarp. J Biomed Biotechnol. 2012;2012:672428. https://doi.org/10.1155/2012/672428.
[78] Shibata MA, Iinuma M, Morimoto J, Kurose H, Akamatsu K, Okuno Y, et al. Alpha-mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation. BMC Med. 2011;9:69. https://doi.org/10.1186/1741-7015-9-69.
[79] Lee YB, Ko KC, Shi MD, Liao YC, Chiang TA, Wu PF, et al. Alpha-mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells. J Food Sci. 2010;75(1):H13-23. https://doi.org/10.1111/j.1750-3841.2009.01407.x.